Delivery Order SPE2DP20D0002-SPE2DP20F6737
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. The contract is a firm-fixed-price delivery order with a potential value of $271,494.00 and a completion date of December 15, 2020. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that has provided various pharmaceutical products, including vaccines, antiviral...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, for the delivery of Adenovirus Type 4 vaccine. The contract has a firm fixed price of $423,530.64 and a completion date of February 23, 2021. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that produces a range of drug products, including vaccines, for U.S. government agencies like the Department of Defense...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned for-profit manufacturer, to provide adenovirus type 4 vaccine. The firm-fixed-price contract has a potential value of $135,747.00 and a completion date of June 23, 2020. Teva Pharmaceuticals has a history of supplying pharmaceutical products, including vaccines, to federal agencies like the Department of Defense and Department of Veterans Affairs under...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price Delivery Order contract to Teva Pharmaceuticals USA, Inc. for the delivery of Adenovirus Type 4 vaccines. The $135,747.00 contract has an August 25, 2020 completion date. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit manufacturer that has provided a range of pharmaceutical products, including vaccines, antiviral medications, and respiratory treatments, to federal customers such as the Department of...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The Firm Fixed Price contract has a potential value of $135,747.00 and a completion date of November 17, 2020. It was awarded on November 3, 2020, and does not have a set-aside designation. Teva Pharmaceuticals USA, Inc. is a subsidiary of Teva Pharmaceutical Industries...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, a $476,414.19 firm-fixed-price delivery order to provide Adenovirus Type 4 vaccine. The contract has a completion date of February 27, 2024. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva Pharmaceutical Industries Ltd. and has been awarded numerous prime contracts by federal agencies such as the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. The firm-fixed-price contract has a potential value of $135,747.00 and a completion date of November 17, 2020. The award was made on November 3, 2020, and there was no set-aside designation. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that has provided various...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $158,804.73 contract, which has no set-aside designation, is for the supply of Adenovirus Type 4 A vaccine with a completion date of February 27, 2024. Teva Pharmaceuticals USA, Inc. has been awarded multiple federal contracts and delivery orders from agencies like the Department of Veterans...
- Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit manufacturer, was awarded a $135,747 delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Adenovirus Type 4 vaccine. The order has a completion date of September 29, 2020 and was issued under a firm-fixed price contract. Teva is an experienced provider of pharmaceutical products, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs, to federal agencies...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $476,414.19 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The contract has a completion date of February 27, 2024 and does not utilize a set-aside designation. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva Pharmaceutical Industries Ltd. and has been awarded numerous prime...
- SPE2DP20D0002Indefinite Delivery Contract
- SPE2DP20D0002-SPE2DP20F6737Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to provide adenovirus type 4 vaccine. The firm-fixed-price contract has a potential value of $135,747.00 and a completion date of August 25, 2020. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that manufactures a range of drug products, including vaccines, antivirals, and respiratory treatments, for federal customers such as the Department of Defense and Department of Veterans Affairs. The company has received numerous delivery orders from DLA Troop Support Medical to support military immunization programs. This contract does not have a set-aside designation.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
ADENOVIRUS TYPE 4 A | SPE2DP18R01130009 | Defense Logistics Agency Troop Support Medical | Award Notice 1/1 | 2/3/20, 2:02 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $135.7k | 8/19/20 |